The global Phentolamine Mesylate Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

Phentolamine mesylate injection is a formulation of phentolamine, a non-selective alpha-adrenergic antagonist, used primarily for the management of hypertensive episodes, particularly in patients with pheochromocytoma. This injectable preparation allows for rapid administration via intravenous or intramuscular routes, providing quick onset of action in acute situations.

North American market for Phentolamine Mesylate Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Phentolamine Mesylate Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Phentolamine Mesylate Injection include Septodont, Hikma, Precision Dose, CR Double-Crane, Sichuan Meida Kangjiale Pharmaceutical, Sunflower Pharmaceutical, Shanghai Fudan Forward Pharmaceuticals, Hainan Poly Pharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Phentolamine Mesylate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phentolamine Mesylate Injection.

The Phentolamine Mesylate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Phentolamine Mesylate Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Phentolamine Mesylate Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Phentolamine Mesylate Injection Market Report

Report Metric	Details
Report Name	Phentolamine Mesylate Injection Market
Segment by Type	Intravenous Injection Intramuscular Injection
Segment by Application	Hospital and Clinic Pharmacy Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Septodont, Hikma, Precision Dose, CR Double-Crane, Sichuan Meida Kangjiale Pharmaceutical, Sunflower Pharmaceutical, Shanghai Fudan Forward Pharmaceuticals, Hainan Poly Pharm
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Phentolamine Mesylate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Phentolamine Mesylate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Phentolamine Mesylate Injection Market report?

Ans: The main players in the Phentolamine Mesylate Injection Market are Septodont, Hikma, Precision Dose, CR Double-Crane, Sichuan Meida Kangjiale Pharmaceutical, Sunflower Pharmaceutical, Shanghai Fudan Forward Pharmaceuticals, Hainan Poly Pharm

What are the Application segmentation covered in the Phentolamine Mesylate Injection Market report?

Ans: The Applications covered in the Phentolamine Mesylate Injection Market report are Hospital and Clinic, Pharmacy, Other

What are the Type segmentation covered in the Phentolamine Mesylate Injection Market report?

Ans: The Types covered in the Phentolamine Mesylate Injection Market report are Intravenous Injection, Intramuscular Injection

1 Phentolamine Mesylate Injection Market Overview

1.1 Product Definition

1.2 Phentolamine Mesylate Injection by Type

1.2.1 Global Phentolamine Mesylate Injection Market Value Comparison by Type (2024-2030)

1.2.2 Intravenous Injection

1.2.3 Intramuscular Injection

1.3 Phentolamine Mesylate Injection by Application

1.3.1 Global Phentolamine Mesylate Injection Market Value by Application (2024-2030)

1.3.2 Hospital and Clinic

1.3.3 Pharmacy

1.3.4 Other

1.4 Global Phentolamine Mesylate Injection Market Size Estimates and Forecasts

1.4.1 Global Phentolamine Mesylate Injection Revenue 2019-2030

1.4.2 Global Phentolamine Mesylate Injection Sales 2019-2030

1.4.3 Global Phentolamine Mesylate Injection Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Phentolamine Mesylate Injection Market Competition by Manufacturers

2.1 Global Phentolamine Mesylate Injection Sales Market Share by Manufacturers (2019-2024)

2.2 Global Phentolamine Mesylate Injection Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Phentolamine Mesylate Injection Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Phentolamine Mesylate Injection, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Phentolamine Mesylate Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Phentolamine Mesylate Injection, Product Type & Application

2.7 Global Key Manufacturers of Phentolamine Mesylate Injection, Date of Enter into This Industry

2.8 Global Phentolamine Mesylate Injection Market Competitive Situation and Trends

2.8.1 Global Phentolamine Mesylate Injection Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Phentolamine Mesylate Injection Players Market Share by Revenue

2.8.3 Global Phentolamine Mesylate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Phentolamine Mesylate Injection Market Scenario by Region

3.1 Global Phentolamine Mesylate Injection Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Phentolamine Mesylate Injection Sales by Region: 2019-2030

3.2.1 Global Phentolamine Mesylate Injection Sales by Region: 2019-2024

3.2.2 Global Phentolamine Mesylate Injection Sales by Region: 2025-2030

3.3 Global Phentolamine Mesylate Injection Revenue by Region: 2019-2030

3.3.1 Global Phentolamine Mesylate Injection Revenue by Region: 2019-2024

3.3.2 Global Phentolamine Mesylate Injection Revenue by Region: 2025-2030

3.4 North America Phentolamine Mesylate Injection Market Facts & Figures by Country

3.4.1 North America Phentolamine Mesylate Injection Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Phentolamine Mesylate Injection Sales by Country (2019-2030)

3.4.3 North America Phentolamine Mesylate Injection Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Phentolamine Mesylate Injection Market Facts & Figures by Country

3.5.1 Europe Phentolamine Mesylate Injection Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Phentolamine Mesylate Injection Sales by Country (2019-2030)

3.5.3 Europe Phentolamine Mesylate Injection Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Phentolamine Mesylate Injection Market Facts & Figures by Region

3.6.1 Asia Pacific Phentolamine Mesylate Injection Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Phentolamine Mesylate Injection Sales by Region (2019-2030)

3.6.3 Asia Pacific Phentolamine Mesylate Injection Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Phentolamine Mesylate Injection Market Facts & Figures by Country

3.7.1 Latin America Phentolamine Mesylate Injection Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Phentolamine Mesylate Injection Sales by Country (2019-2030)

3.7.3 Latin America Phentolamine Mesylate Injection Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Phentolamine Mesylate Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Phentolamine Mesylate Injection Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Phentolamine Mesylate Injection Sales by Country (2019-2030)

3.8.3 Middle East and Africa Phentolamine Mesylate Injection Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Phentolamine Mesylate Injection Sales by Type (2019-2030)

4.1.1 Global Phentolamine Mesylate Injection Sales by Type (2019-2024)

4.1.2 Global Phentolamine Mesylate Injection Sales by Type (2025-2030)

4.1.3 Global Phentolamine Mesylate Injection Sales Market Share by Type (2019-2030)

4.2 Global Phentolamine Mesylate Injection Revenue by Type (2019-2030)

4.2.1 Global Phentolamine Mesylate Injection Revenue by Type (2019-2024)

4.2.2 Global Phentolamine Mesylate Injection Revenue by Type (2025-2030)

4.2.3 Global Phentolamine Mesylate Injection Revenue Market Share by Type (2019-2030)

4.3 Global Phentolamine Mesylate Injection Price by Type (2019-2030)

5 Segment by Application

5.1 Global Phentolamine Mesylate Injection Sales by Application (2019-2030)

5.1.1 Global Phentolamine Mesylate Injection Sales by Application (2019-2024)

5.1.2 Global Phentolamine Mesylate Injection Sales by Application (2025-2030)

5.1.3 Global Phentolamine Mesylate Injection Sales Market Share by Application (2019-2030)

5.2 Global Phentolamine Mesylate Injection Revenue by Application (2019-2030)

5.2.1 Global Phentolamine Mesylate Injection Revenue by Application (2019-2024)

5.2.2 Global Phentolamine Mesylate Injection Revenue by Application (2025-2030)

5.2.3 Global Phentolamine Mesylate Injection Revenue Market Share by Application (2019-2030)

5.3 Global Phentolamine Mesylate Injection Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Septodont

6.1.1 Septodont Company Information

6.1.2 Septodont Description and Business Overview

6.1.3 Septodont Phentolamine Mesylate Injection Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Septodont Phentolamine Mesylate Injection Product Portfolio

6.1.5 Septodont Recent Developments/Updates

6.2 Hikma

6.2.1 Hikma Company Information

6.2.2 Hikma Description and Business Overview

6.2.3 Hikma Phentolamine Mesylate Injection Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Hikma Phentolamine Mesylate Injection Product Portfolio

6.2.5 Hikma Recent Developments/Updates

6.3 Precision Dose

6.3.1 Precision Dose Company Information

6.3.2 Precision Dose Description and Business Overview

6.3.3 Precision Dose Phentolamine Mesylate Injection Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Precision Dose Phentolamine Mesylate Injection Product Portfolio

6.3.5 Precision Dose Recent Developments/Updates

6.4 CR Double-Crane

6.4.1 CR Double-Crane Company Information

6.4.2 CR Double-Crane Description and Business Overview

6.4.3 CR Double-Crane Phentolamine Mesylate Injection Sales, Revenue and Gross Margin (2019-2024)

6.4.4 CR Double-Crane Phentolamine Mesylate Injection Product Portfolio

6.4.5 CR Double-Crane Recent Developments/Updates

6.5 Sichuan Meida Kangjiale Pharmaceutical

6.5.1 Sichuan Meida Kangjiale Pharmaceutical Company Information

6.5.2 Sichuan Meida Kangjiale Pharmaceutical Description and Business Overview

6.5.3 Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Product Portfolio

6.5.5 Sichuan Meida Kangjiale Pharmaceutical Recent Developments/Updates

6.6 Sunflower Pharmaceutical

6.6.1 Sunflower Pharmaceutical Company Information

6.6.2 Sunflower Pharmaceutical Description and Business Overview

6.6.3 Sunflower Pharmaceutical Phentolamine Mesylate Injection Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Sunflower Pharmaceutical Phentolamine Mesylate Injection Product Portfolio

6.6.5 Sunflower Pharmaceutical Recent Developments/Updates

6.7 Shanghai Fudan Forward Pharmaceuticals

6.7.1 Shanghai Fudan Forward Pharmaceuticals Company Information

6.7.2 Shanghai Fudan Forward Pharmaceuticals Description and Business Overview

6.7.3 Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Product Portfolio

6.7.5 Shanghai Fudan Forward Pharmaceuticals Recent Developments/Updates

6.8 Hainan Poly Pharm

6.8.1 Hainan Poly Pharm Company Information

6.8.2 Hainan Poly Pharm Description and Business Overview

6.8.3 Hainan Poly Pharm Phentolamine Mesylate Injection Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Hainan Poly Pharm Phentolamine Mesylate Injection Product Portfolio

6.8.5 Hainan Poly Pharm Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Phentolamine Mesylate Injection Industry Chain Analysis

7.2 Phentolamine Mesylate Injection Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Phentolamine Mesylate Injection Production Mode & Process

7.4 Phentolamine Mesylate Injection Sales and Marketing

7.4.1 Phentolamine Mesylate Injection Sales Channels

7.4.2 Phentolamine Mesylate Injection Distributors

7.5 Phentolamine Mesylate Injection Customers

8 Phentolamine Mesylate Injection Market Dynamics

8.1 Phentolamine Mesylate Injection Industry Trends

8.2 Phentolamine Mesylate Injection Market Drivers

8.3 Phentolamine Mesylate Injection Market Challenges

8.4 Phentolamine Mesylate Injection Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sichuan Meida Kangjiale Pharmaceutical

Sunflower Pharmaceutical

Shanghai Fudan Forward Pharmaceuticals

Hainan Poly Pharm

List of Tables

Table 1. Global Phentolamine Mesylate Injection Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Phentolamine Mesylate Injection Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Phentolamine Mesylate Injection Market Competitive Situation by Manufacturers in 2023

Table 4. Global Phentolamine Mesylate Injection Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Phentolamine Mesylate Injection Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Phentolamine Mesylate Injection Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Phentolamine Mesylate Injection Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Phentolamine Mesylate Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Phentolamine Mesylate Injection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Phentolamine Mesylate Injection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Phentolamine Mesylate Injection, Product Type & Application

Table 12. Global Key Manufacturers of Phentolamine Mesylate Injection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Phentolamine Mesylate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phentolamine Mesylate Injection as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Phentolamine Mesylate Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Phentolamine Mesylate Injection Sales by Region (2019-2024) & (K Units)

Table 18. Global Phentolamine Mesylate Injection Sales Market Share by Region (2019-2024)

Table 19. Global Phentolamine Mesylate Injection Sales by Region (2025-2030) & (K Units)

Table 20. Global Phentolamine Mesylate Injection Sales Market Share by Region (2025-2030)

Table 21. Global Phentolamine Mesylate Injection Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Phentolamine Mesylate Injection Revenue Market Share by Region (2019-2024)

Table 23. Global Phentolamine Mesylate Injection Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Phentolamine Mesylate Injection Revenue Market Share by Region (2025-2030)

Table 25. North America Phentolamine Mesylate Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Phentolamine Mesylate Injection Sales by Country (2019-2024) & (K Units)

Table 27. North America Phentolamine Mesylate Injection Sales by Country (2025-2030) & (K Units)

Table 28. North America Phentolamine Mesylate Injection Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Phentolamine Mesylate Injection Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Phentolamine Mesylate Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Phentolamine Mesylate Injection Sales by Country (2019-2024) & (K Units)

Table 32. Europe Phentolamine Mesylate Injection Sales by Country (2025-2030) & (K Units)

Table 33. Europe Phentolamine Mesylate Injection Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Phentolamine Mesylate Injection Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Phentolamine Mesylate Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Phentolamine Mesylate Injection Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Phentolamine Mesylate Injection Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Phentolamine Mesylate Injection Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Phentolamine Mesylate Injection Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Phentolamine Mesylate Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Phentolamine Mesylate Injection Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Phentolamine Mesylate Injection Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Phentolamine Mesylate Injection Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Phentolamine Mesylate Injection Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Phentolamine Mesylate Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Phentolamine Mesylate Injection Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Phentolamine Mesylate Injection Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Phentolamine Mesylate Injection Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Phentolamine Mesylate Injection Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Phentolamine Mesylate Injection Sales (K Units) by Type (2019-2024)

Table 51. Global Phentolamine Mesylate Injection Sales (K Units) by Type (2025-2030)

Table 52. Global Phentolamine Mesylate Injection Sales Market Share by Type (2019-2024)

Table 53. Global Phentolamine Mesylate Injection Sales Market Share by Type (2025-2030)

Table 54. Global Phentolamine Mesylate Injection Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Phentolamine Mesylate Injection Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Phentolamine Mesylate Injection Revenue Market Share by Type (2019-2024)

Table 57. Global Phentolamine Mesylate Injection Revenue Market Share by Type (2025-2030)

Table 58. Global Phentolamine Mesylate Injection Price (US$/Unit) by Type (2019-2024)

Table 59. Global Phentolamine Mesylate Injection Price (US$/Unit) by Type (2025-2030)

Table 60. Global Phentolamine Mesylate Injection Sales (K Units) by Application (2019-2024)

Table 61. Global Phentolamine Mesylate Injection Sales (K Units) by Application (2025-2030)

Table 62. Global Phentolamine Mesylate Injection Sales Market Share by Application (2019-2024)

Table 63. Global Phentolamine Mesylate Injection Sales Market Share by Application (2025-2030)

Table 64. Global Phentolamine Mesylate Injection Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Phentolamine Mesylate Injection Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Phentolamine Mesylate Injection Revenue Market Share by Application (2019-2024)

Table 67. Global Phentolamine Mesylate Injection Revenue Market Share by Application (2025-2030)

Table 68. Global Phentolamine Mesylate Injection Price (US$/Unit) by Application (2019-2024)

Table 69. Global Phentolamine Mesylate Injection Price (US$/Unit) by Application (2025-2030)

Table 70. Septodont Company Information

Table 71. Septodont Description and Business Overview

Table 72. Septodont Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Septodont Phentolamine Mesylate Injection Product

Table 74. Septodont Recent Developments/Updates

Table 75. Hikma Company Information

Table 76. Hikma Description and Business Overview

Table 77. Hikma Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Hikma Phentolamine Mesylate Injection Product

Table 79. Hikma Recent Developments/Updates

Table 80. Precision Dose Company Information

Table 81. Precision Dose Description and Business Overview

Table 82. Precision Dose Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Precision Dose Phentolamine Mesylate Injection Product

Table 84. Precision Dose Recent Developments/Updates

Table 85. CR Double-Crane Company Information

Table 86. CR Double-Crane Description and Business Overview

Table 87. CR Double-Crane Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. CR Double-Crane Phentolamine Mesylate Injection Product

Table 89. CR Double-Crane Recent Developments/Updates

Table 90. Sichuan Meida Kangjiale Pharmaceutical Company Information

Table 91. Sichuan Meida Kangjiale Pharmaceutical Description and Business Overview

Table 92. Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Sichuan Meida Kangjiale Pharmaceutical Phentolamine Mesylate Injection Product

Table 94. Sichuan Meida Kangjiale Pharmaceutical Recent Developments/Updates

Table 95. Sunflower Pharmaceutical Company Information

Table 96. Sunflower Pharmaceutical Description and Business Overview

Table 97. Sunflower Pharmaceutical Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Sunflower Pharmaceutical Phentolamine Mesylate Injection Product

Table 99. Sunflower Pharmaceutical Recent Developments/Updates

Table 100. Shanghai Fudan Forward Pharmaceuticals Company Information

Table 101. Shanghai Fudan Forward Pharmaceuticals Description and Business Overview

Table 102. Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Shanghai Fudan Forward Pharmaceuticals Phentolamine Mesylate Injection Product

Table 104. Shanghai Fudan Forward Pharmaceuticals Recent Developments/Updates

Table 105. Hainan Poly Pharm Company Information

Table 106. Hainan Poly Pharm Description and Business Overview

Table 107. Hainan Poly Pharm Phentolamine Mesylate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Hainan Poly Pharm Phentolamine Mesylate Injection Product

Table 109. Hainan Poly Pharm Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Phentolamine Mesylate Injection Distributors List

Table 113. Phentolamine Mesylate Injection Customers List

Table 114. Phentolamine Mesylate Injection Market Trends

Table 115. Phentolamine Mesylate Injection Market Drivers

Table 116. Phentolamine Mesylate Injection Market Challenges

Table 117. Phentolamine Mesylate Injection Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Phentolamine Mesylate Injection

Figure 2. Global Phentolamine Mesylate Injection Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Phentolamine Mesylate Injection Market Share by Type: 2023 & 2030

Figure 4. Intravenous Injection Product Picture

Figure 5. Intramuscular Injection Product Picture

Figure 6. Global Phentolamine Mesylate Injection Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Phentolamine Mesylate Injection Market Share by Application: 2023 & 2030

Figure 8. Hospital and Clinic

Figure 9. Pharmacy

Figure 10. Other

Figure 11. Global Phentolamine Mesylate Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Phentolamine Mesylate Injection Market Size (2019-2030) & (US$ Million)

Figure 13. Global Phentolamine Mesylate Injection Sales (2019-2030) & (K Units)

Figure 14. Global Phentolamine Mesylate Injection Average Price (US$/Unit) & (2019-2030)

Figure 15. Phentolamine Mesylate Injection Report Years Considered

Figure 16. Phentolamine Mesylate Injection Sales Share by Manufacturers in 2023

Figure 17. Global Phentolamine Mesylate Injection Revenue Share by Manufacturers in 2023

Figure 18. Global 5 and 10 Largest Phentolamine Mesylate Injection Players: Market Share by Revenue in Phentolamine Mesylate Injection in 2023

Figure 19. Phentolamine Mesylate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 20. Global Phentolamine Mesylate Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Phentolamine Mesylate Injection Sales Market Share by Country (2019-2030)

Figure 22. North America Phentolamine Mesylate Injection Revenue Market Share by Country (2019-2030)

Figure 23. United States Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Phentolamine Mesylate Injection Sales Market Share by Country (2019-2030)

Figure 26. Europe Phentolamine Mesylate Injection Revenue Market Share by Country (2019-2030)

Figure 27. Germany Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Phentolamine Mesylate Injection Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Phentolamine Mesylate Injection Revenue Market Share by Region (2019-2030)

Figure 34. China Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Phentolamine Mesylate Injection Sales Market Share by Country (2019-2030)

Figure 42. Mexico Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Colombia Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East and Africa Phentolamine Mesylate Injection Sales Market Share by Country (2019-2030)

Figure 47. Middle East and Africa Phentolamine Mesylate Injection Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Phentolamine Mesylate Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Phentolamine Mesylate Injection by Type (2019-2030)

Figure 52. Global Revenue Market Share of Phentolamine Mesylate Injection by Type (2019-2030)

Figure 53. Global Phentolamine Mesylate Injection Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Phentolamine Mesylate Injection by Application (2019-2030)

Figure 55. Global Revenue Market Share of Phentolamine Mesylate Injection by Application (2019-2030)

Figure 56. Global Phentolamine Mesylate Injection Price (US$/Unit) by Application (2019-2030)

Figure 57. Phentolamine Mesylate Injection Value Chain

Figure 58. Phentolamine Mesylate Injection Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions